GeneFab
Alameda, CA and South San Francisco
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
61.5
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
○ EMA GMP
○ MHRA GMP
Quick Facts: GeneFab
- Signal Score
- 61.5/100 (as of 2026-10-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Alameda, CA and South San Francisco
- Founded
- 2023
- Max Bioreactor Scale
- 200L
- Website
- https://www.genefab.com
- Modalities
- Cell Therapies, Autologous therapies, Allogeneic therapies, Stem cell therapies, Gene-Modified Cell Therapy, Lentiviral, gamma-retroviral
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About GeneFab
Examples of our GMP manufacturing support and strategic partnerships: GeneFab conducts the clinical manufacturing of Senti Bio’s chimeric antigen receptor natural killer (CAR-NK) medicines pipeline, SENTI-202. https://investors.sentibio.com/news-releases/news-release-details/senti-bio-announces-closing-transaction-leveraging-its-cmc; and Patnership with RegCell to advance their regulatory T cell (Treg) therapies for autoimmune diseases, https://www.outsourcedpharma.com/doc/genefab-regcell-announce-partnership-advance-autoimmune-cell-therapy-clinical-trials-0001
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapies, Autologous therapies, Allogeneic therapies, Stem cell therapies, Gene-Modified Cell Therapy, Lentiviral, gamma-retroviral
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
63.0
Broad modality coverage (7 modalities)
Sites: Alameda, CA
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
StatusAvailable
Broad modality coverage (7 modalities)
Sites: Alameda, CA
Broad modality coverage (7 modalities)
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Frequently Asked Questions About GeneFab
What is GeneFab's CDMO Signal Score?
GeneFab has a Signal Score of 62/100, based on quality, operations, financial stability, and capacity data.
Evaluating GeneFab for a manufacturing program?
Use the free AI matchmaker to compare GeneFab against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
August Bioservices
San Carlos, CA
Signal Score: 77.6
AAV, Lentiviral
National Resilience
San Diego, CA · Boston, MA · RTP, NC · Philadelphia, PA
Signal Score: 73.6
mRNA, Gene Therapy, Cell Therapy, Lentiviral
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 82.9
AAV, Lentiviral, Plasmid, mRNA
Compare GeneFab with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.